These findings suggest that patients with CYP27A1 variants may present the broader clinical spectrum including HSP phenotype, nonetheless the lack of the typical symptoms of CTX, especially xantomas, should not exclude the investigation of CYP27A1 gene mutations. The gene discussed is CYP27A1; the disease is hereditary spastic paraplegia.